High versus standard adalimumab induction dosing regimens in patients with moderately to severely active Crohn's disease: Results from the SERENE-CD induction study

Geert D‘Haens  1     William Sandborn  2     Edward Loftus  3     Steve Hanauer  4     Stefan Schreiber  5     Laurent Peyrin-Biroulet  6     Remo Panaccione     Julian Panés     Jean-Frédéric Colombel     Marc Ferrante     Edouard Louis     Alessandro Armuzzi     Qian Zhou     Bidan Huang     Nisha V. Kwatra     Nael M. Mostafa     Thao Doan     Joel Petersson     Alex Song     Anne M. Robinso    
1 Amsterdam University Medical Centers,Amsterdam,Netherlands
2 University of California San Diego,San Diego,United States
3 Mayo Clinic,Rochester,United States
4 Feinberg School of Medicine, Northwestern University,Chicago,United States
5 University Hospital Schleswig-Holstein,Kiel,Germany
6 Nancy University Hospital Inserm U954 Dept. of Hep

UEG Week 2019

United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019

Login to access library content


Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing